Skip to main content
Tech.euFundingExplorerBeta

Healthtech funding in H1 2021

European Healthtech startup funding raised during H1 2021.

In H1 2021, 230 European Healthtech companies closed 232 funding rounds and raised €3.7B in equity funding (excluding debt and grants), up 54.2% versus H1 2020. Debt rounds added €190M. UK led by capital raised, and Accel was the most active investor. Data as of 20 Nov 2026.

Equity funding
€3.7B
+54.2% vs H1 2020 · excl. debt & grants · +€190M debt
Funding rounds
232
+14.3% vs H1 2020
Companies
230
Top country
UK
Rank among sectors
#5
5.9% of sector funding
Debt financing
€190M
4.9% of total
Top-10 round share
38.7%
of disclosed capital
Rounds ≥ €100M
7

Funding by month

€ raised vs rounds, by month
Healthtech — funding by month, H1 2021 — interactive chart.
Data table
FundingRounds
Jan€597M34
Feb€476M27
Mar€497M34
Apr€818M37
May€864M51
Jun€660M49

Top countries

by € raised
Healthtech — top countries by capital, H1 2021 — interactive chart.
Data table
Healthtech — top countries by capital, H1 2021
UK€1.4B
Germany€562M
Israel€472M
Sweden€434M
Switzerland€296M
Spain€232M
Netherlands€161M
Denmark€153M

Stage mix

by € raised
Healthtech — stage mix, H1 2021 — interactive chart.
Data table
Healthtech — stage mix, H1 2021
Other€1.3B
Series D+€709M
Series C€650M
Series B€559M
Series A€374M
Debt€190M
Seed€109M
Growth/Late€58M
Crowdfunding€9.6M
Early VC€2.3M
Pre-Seed€655k
Grant€401k

Exits & M&A

15 Acquisition · 2 IPO

17 exits · €1.4B disclosed.

Arvelle TherapeuticsAcquisitionJan 2021€784M
BabylonIPOJun 2021€470M
GinolisAcquisitionFeb 2021€70M
MatTekAcquisitionMar 2021€57M

Top deals

largest disclosed rounds in H1 2021
CompanyStageDateAmount
KrySeries D+Apr 2021€262M
Oxford Nanopore TechnologiesOtherMay 2021€225M
QuantaSeries D+Jun 2021€205M
ImmunocoreDebtFeb 2021€190M
Atai Life SciencesSeries D+Mar 2021€131M
IO BiotechSeries BJan 2021€127M
HumaSeries CMay 2021€107M
CeQurSeries CApr 2021€97M
MelioSeries CJan 2021€90M
Evox TherapeuticsSeries CFeb 2021€80M
Monte RosaSeries CMar 2021€80M
LumicksOtherApr 2021€77M
Ada healthSeries BMay 2021€74M
Alchemab TherapeuticsSeries AApr 2021€69M
Kaia HealthSeries D+Apr 2021€62M

Top investors

most active in H1 2021, by deal count